|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61B 5/00 | |
| A61K 51/10 | |||
| G01N 33/53 | |||
| A61K 51/00 | |||
| A61K 39/395 | |||
| A61K 38/00 | |||
| G01N 33/574 |
| (11) | Number of the document | 2771688 |
| (13) | Kind of document | T |
| (96) | European patent application number | 12844178.9 |
| Date of filing the European patent application | 2012-10-25 | |
| (97) | Date of publication of the European application | 2014-09-03 |
| (45) | Date of publication and mention of the grant of the patent | 2018-09-26 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2012/061982 |
| Date | 2012-10-25 |
| (87) | Number | WO 2013/063312 |
| Date | 2013-05-02 |
| (30) | Number | Date | Country code |
| 201161551195 P | 2011-10-25 | US |
| (72) |
SAWYERS, Charles, US
ULMERT, David, US
LEWIS, Jason, US
EVANS, Michael, US
LIJA, Hans, US
|
| (73) |
Memorial Sloan-Kettering Cancer Center,
1275 York Avenue, New York, NY 10065,
US
|
| (54) | FREE PSA ANTIBODIES AS DIAGNOSTICS, PROGNOSTICS AND THERAPEUTICS FOR PROSTATE CANCER |
| FREE PSA ANTIBODIES AS DIAGNOSTICS, PROGNOSTICS AND THERAPEUTICS FOR PROSTATE CANCER |